323 related articles for article (PubMed ID: 33044494)
1. Concordance Between Blood Pressure in the Systolic Blood Pressure Intervention Trial and in Routine Clinical Practice.
Drawz PE; Agarwal A; Dwyer JP; Horwitz E; Lash J; Lenoir K; McWilliams A; Oparil S; Rahbari-Oskoui F; Rahman M; Parkulo MA; Pemu P; Raj DS; Rocco M; Soman S; Thomas G; Tuot DS; Whelton PK; Pajewski NM
JAMA Intern Med; 2020 Dec; 180(12):1655-1663. PubMed ID: 33044494
[TBL] [Abstract][Full Text] [Related]
2. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study.
Drawz PE; Pajewski NM; Bates JT; Bello NA; Cushman WC; Dwyer JP; Fine LJ; Goff DC; Haley WE; Krousel-Wood M; McWilliams A; Rifkin DE; Slinin Y; Taylor A; Townsend R; Wall B; Wright JT; Rahman M
Hypertension; 2017 Jan; 69(1):42-50. PubMed ID: 27849563
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
Vaduganathan M; Claggett BL; Juraschek SP; Solomon SD
JAMA Cardiol; 2020 May; 5(5):576-581. PubMed ID: 32101262
[TBL] [Abstract][Full Text] [Related]
4. Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial).
Johnson KC; Whelton PK; Cushman WC; Cutler JA; Evans GW; Snyder JK; Ambrosius WT; Beddhu S; Cheung AK; Fine LJ; Lewis CE; Rahman M; Reboussin DM; Rocco MV; Oparil S; Wright JT;
Hypertension; 2018 May; 71(5):848-857. PubMed ID: 29531173
[TBL] [Abstract][Full Text] [Related]
5. Implications of Blood Pressure Measurement Technique for Implementation of Systolic Blood Pressure Intervention Trial (SPRINT).
Agarwal R
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159816
[TBL] [Abstract][Full Text] [Related]
6. Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT.
Ghazi L; Pajewski NM; Rifkin DE; Bates JT; Chang TI; Cushman WC; Glasser SP; Haley WE; Johnson KC; Kostis WJ; Papademetriou V; Rahman M; Simmons DL; Taylor A; Whelton PK; Wright JT; Bhatt UY; Drawz PE
J Am Heart Assoc; 2019 Jul; 8(14):e011706. PubMed ID: 31307270
[TBL] [Abstract][Full Text] [Related]
7. Long-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults With Uncontrolled Hypertension: Follow-up of a Cluster Randomized Clinical Trial.
Margolis KL; Asche SE; Dehmer SP; Bergdall AR; Green BB; Sperl-Hillen JM; Nyboer RA; Pawloski PA; Maciosek MV; Trower NK; O'Connor PJ
JAMA Netw Open; 2018 Sep; 1(5):e181617. PubMed ID: 30646139
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Effect of Home Blood Pressure Self-Monitoring Plus Medication Self-Titration for Patients With Hypertension: A Secondary Analysis of the ADAMPA Randomized Clinical Trial.
Martínez-Ibáñez P; Marco-Moreno I; García-Sempere A; Peiró S; Martínez-Ibáñez L; Barreira-Franch I; Bellot-Pujalte L; Avelino-Hidalgo E; Escrig-Veses M; Bóveda-García M; Calleja-Del-Ser M; Robles-Cabaniñas C; Hurtado I; Rodríguez-Bernal CL; Giménez-Loreiro M; Sanfélix-Gimeno G; Sanfélix-Genovés J;
JAMA Netw Open; 2024 May; 7(5):e2410063. PubMed ID: 38728033
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical Trial.
Zheutlin AR; Mondesir FL; Derington CG; King JB; Zhang C; Cohen JB; Berlowitz DR; Anstey DE; Cushman WC; Greene TH; Ogedegbe O; Bress AP
JAMA Netw Open; 2022 Jan; 5(1):e2143001. PubMed ID: 35006243
[TBL] [Abstract][Full Text] [Related]
10. Effect of Intensive Blood Pressure Control on Gait Speed and Mobility Limitation in Adults 75 Years or Older: A Randomized Clinical Trial.
Odden MC; Peralta CA; Berlowitz DR; Johnson KC; Whittle J; Kitzman DW; Beddhu S; Nord JW; Papademetriou V; Williamson JD; Pajewski NM;
JAMA Intern Med; 2017 Apr; 177(4):500-507. PubMed ID: 28166324
[TBL] [Abstract][Full Text] [Related]
11. Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial.
Ghazi L; Shen J; Ying J; Derington CG; Cohen JB; Marcum ZA; Herrick JS; King JB; Cheung AK; Williamson JD; Pajewski NM; Bryan N; Supiano M; Sonnen J; Weintraub WS; Greene TH; Bress AP
JAMA Netw Open; 2023 May; 6(5):e2314443. PubMed ID: 37204788
[TBL] [Abstract][Full Text] [Related]
12. Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical Trial.
Jaeger BC; Bress AP; Bundy JD; Cheung AK; Cushman WC; Drawz PE; Johnson KC; Lewis CE; Oparil S; Rocco MV; Rapp SR; Supiano MA; Whelton PK; Williamson JD; Wright JT; Reboussin DM; Pajewski NM
JAMA Cardiol; 2022 Nov; 7(11):1138-1146. PubMed ID: 36223105
[TBL] [Abstract][Full Text] [Related]
13. Remote Blood Pressure Monitoring With Social Support for Patients With Hypertension: A Randomized Clinical Trial.
Mehta SJ; Volpp KG; Troxel AB; Teel J; Reitz CR; Purcell A; Shen H; McNelis K; Snider CK; Asch DA
JAMA Netw Open; 2024 Jun; 7(6):e2413515. PubMed ID: 38829618
[TBL] [Abstract][Full Text] [Related]
14. Association of Intensive vs Standard Blood Pressure Control With Regional Changes in Cerebral Small Vessel Disease Biomarkers: Post Hoc Secondary Analysis of the SPRINT MIND Randomized Clinical Trial.
Rashid T; Li K; Toledo JB; Nasrallah I; Pajewski NM; Dolui S; Detre J; Wolk DA; Liu H; Heckbert SR; Bryan RN; Williamson J; Davatzikos C; Seshadri S; Launer LJ; Habes M
JAMA Netw Open; 2023 Mar; 6(3):e231055. PubMed ID: 36857053
[TBL] [Abstract][Full Text] [Related]
15. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
Staessen JA; Thijs L; Fagard R; O'Brien ET; Clement D; de Leeuw PW; Mancia G; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J
JAMA; 1999 Aug; 282(6):539-46. PubMed ID: 10450715
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
Scarpa J; Bruzelius E; Doupe P; Le M; Faghmous J; Baum A
JAMA Netw Open; 2019 Mar; 2(3):e190005. PubMed ID: 30848803
[TBL] [Abstract][Full Text] [Related]
17. Measuring blood pressure for decision making and quality reporting: where and how many measures?
Powers BJ; Olsen MK; Smith VA; Woolson RF; Bosworth HB; Oddone EZ
Ann Intern Med; 2011 Jun; 154(12):781-8, W-289-90. PubMed ID: 21690592
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Blood Pressure Measurements from Clinical Practice and a Research Study At Kaiser Permanente Southern California.
Sanders MA; Muntner P; Wei R; Shimbo D; Schwartz JE; Qian L; Bowling CB; Cannavale K; Harrison TN; Lustigova E; Sim JJ; Reynolds K
Am J Hypertens; 2023 May; 36(6):283-286. PubMed ID: 36851820
[TBL] [Abstract][Full Text] [Related]
19. Association of Intensive Blood Pressure Control and Living Arrangement on Cardiovascular Outcomes by Race: Post Hoc Analysis of SPRINT Randomized Clinical Trial.
Inoue K; Watson KE; Kondo N; Horwich T; Hsu W; Bui AAT; Duru OK
JAMA Netw Open; 2022 Mar; 5(3):e222037. PubMed ID: 35285922
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular Risk in Hypertension in Relation to Achieved Blood Pressure Using Automated Office Blood Pressure Measurement.
Myers MG; Kaczorowski J; Dolovich L; Tu K; Paterson JM
Hypertension; 2016 Oct; 68(4):866-72. PubMed ID: 27528062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
